156 results
Page 5 of 8
8-K
EX-99.1
bjpq7w22q41sb0
30 Sep 09
Incyte Announces Closing of Public Offering of Common Stock
12:00am
8-K
EX-10.1
qxcs8y
30 Sep 09
Incyte Announces Closing of Public Offering of Common Stock
12:00am
8-K
EX-99.1
r0g4xmv6c45o
25 Sep 09
Incyte Announces Pricing of Public Offering of 18,000,000 Shares of Common Stock
12:00am
8-K
EX-1.1
wjui8v1pf k3my6dw
25 Sep 09
Incyte Announces Pricing of Public Offering of 18,000,000 Shares of Common Stock
12:00am
FWP
n4u89x sl
25 Sep 09
Free writing prospectus
12:00am
8-K
EX-99.1
jgggcvp
21 Jul 09
Incyte Reaches Agreement with FDA on a Special Protocol Assessment
12:00am
POSASR
EX-4.1
9tsnzfn
12 Feb 09
Automatic shelf registration (post-effective amendment)
12:00am
8-K
EX-1.1
syukxfrkfkafc gtlo
1 Aug 08
Incyte Announces Pricing of Public Offering of
12:00am
8-K
EX-99.1
nhnwdgykdzqhf3obm
1 Aug 08
Incyte Announces Pricing of Public Offering of
12:00am
424B3
labjoe09 dsr
8 Dec 06
Prospectus supplement
12:00am